Non-Parathyroid Hypercalcemia

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition

Volumn , Issue , 2013, Pages 562-571

  Horwitz, Mara J ^a   Hodak, Steven P ^a   Stewart, Andrew F ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Granulomatous diseases; Malignancy associated hypercalcemia (MAHC); Non parathyroid hypercalcemia

Indexed keywords

EID: 85014415416     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118453926.ch70     Document Type: Chapter

References (57)

1. Horwitz MJ, Stewart AF. 2010. Malignancy-associated hypercalcemia and medical management. In: DeGroot L, Jameson L (eds.) Endocrinology, 6th Ed. Philadelphia, PA: Saunders Elsevier. pp. 1198-1211.
2. Stewart AF, Horst R, Deftos LJ, Cadman EC, Lang R, Broadus AE. 1980. Biochemical evaluation of patients with cancer-associated hypercalcemia: Evidence for humoral and non-humoral groups. N Engl J Med 303: 1377-1383.
3. Burtis WJ, Brady TG, Orloff JJ, Ersbak JB, Warrell RP, Olson BR, Wu TL, Mitnick, MA, Broadus AE, Stewart AF. 1990. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of malignancy. New Engl J Med 322: 1106-1112.
4. Stewart AF, Vignery A, Silvergate A, Ravin ND, LiVolsi V, Broadus AE, Baron R. 1982. Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: Uncoupling of bone cell activity. J Clin Endo Metab 55: 219-227.
5. Horwitz MJ, Tedesco MB, Sereika SK, Prebehala L, Gundberg CM, Hollis BW, Bisello A, Carneiro RM, Garcia-Ocaña A, Stewart AF. 2011. A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover. Modeling hyperparathyroidism, humoral hypercalcemia of malignancy and lactation in humans: continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover. J Bone Miner Res 26 (9): 2287-2297.
6. Stewart AF. 2005. Hypercalcemia associated with cancer. N Engl J Med 352: 373-379.
7. Dean T, Vilardaga J-P, Potts JT, Gardella TJ. 2008. Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor. Mol Endo 22: 156-166.
8. Knecht TP, Behling CA, Burton DW, Glass CK, Deftos LJ. 1996. The humoral hypercalcemia of benignancy. A newly appreciated syndrome. Am J Clin Pathol 105: 487-492.
9. Khosla S, van Heerden JA, Gharib H, Jackson IT, Danks J, Hayman JA, Martin TJ. 1990. Parathyroid hormonerelated protein and hypercalcemia secondary to massive mammary hyperplasia. N Engl J Med 322: 1157.
10. Roodman GD. 2004. Mechanisms of bone metastasis. N Engl J Med 350: 1655-1664.
11. Rosenthal N, Insogna KL, Godsall JW, Smaldone L, Waldron JA, Stewart AF. 1985. Elevations in circulating 1,25 dihydroxyvitamin D in three patients with lymphoma-associated hypercalcemia. J Clin Endocrinol Metab 60: 29-33.
12. Evans KN, Taylor H, Zehnder D, Kilby MD, Bulmer JN, Shah F, Adams JS, Hewison M. 2004. Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: A novel form of humoral hypercalcemia of malignancy. Am J Pathol 165: 807-813.
13. Nussbaum SR, Gaz RD, Arnold A. 1990. Hypercalcemia and ectopic secretion of PTH by an ovarian carcinoma with rearrangement of the gene for PTH. N Engl J Med 323: 1324-1328.
14. VanHouten JN, Yu N, Rimm D, Dotto J, Arnold A, Wysolmerski JJ, Udelsman R. 2006. Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene. J Clin Endocrinol Metab 91: 580-583.
15. Barbour GL, Coburn JW, Slatopolsky E, Norman AW, Horst RL. 1981. Hypercalcemia in an anephric patient with sarcoidosis: Evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med 305: 440-443.
16. Adams JS, Gacad MA. 1985. Characterization of 1 hydroxylation of vitamin D 3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 161: 755-765.
17. Parker MS, Dokoh S, Woolfenden JM, Buchsbaum HW. 1984. Hypercalcemia in coccidioidomycosis. Am J Med 76: 341-343.
18. Gkonos PJ, London R, Hendler ED. 1984. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end stage renal disease and active tuberculosis. N Engl J Med 311: 1683-1685.
19. Ross DS, Nussbaum SR. 1989. Reciprocal changes in parathyroid hormone and thyroid function after radioiodine treatment of hyperthyroidism. J Clin Endocrinol Metab 68: 1216-1219.
20. Rosen HN, Moses AC, Gundberg C, Kung VT, Seyedin SM, Chen T, Holick M, Greenspan SL. 1993. Therapy with parenteral pamidronate prevents thyroid hormoneinduced bone turnover in humans. J Clin Endocrinol Metab 77: 664-669.
21. Muls E, Bouillon R, Boelaert J, Lamberigts G, Van Imschool S, Daneels P, DeMoor P. 1982. Etiology of hypercalcemia in a patient with Addison's disease. Calcif Tissue Int 34: 523-526.
22. Vasikaran SD, Tallis GA, Braund WJ. 1994. Secondary hypoadrenalism presenting with hypercalcaemia. Clin Endocrinol 41: 261-265.
23. Verner JV, Morrison AB. 1974. Endocrine pancreatic islet disease with diarrhea. Arch Intern Med 133: 492-500.
24. Ghaferi AA, Chojnacki KA, Long, WD, Cameron JL, Yeo CJ. 2008. Pancreatic VIPomas: Subject review and one institutional experience. J Gastrointest Surg 12: 382-393.
25. Stewart AF, Hoecker J, Segre GV, Mallette LE, Amatruda T, Vignery A. 1985. Hypercalcemia in pheochromocytoma: Evidence for a novel mechanism. Ann Intern Med 102: 776-779.
26. Mune T, Katakami H, Kato Y, Yasuda K, Matsukura S, Miura K. 1993. Production and secretion of parathyroid hormone-related protein in pheochromocytoma: Participation of an α-adrenergic mechanism. J Clin Endocrinol Metab 76: 757-762.
27. Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE. 1982. Calcium homeostasis in immobilization: An example of resorptive hypercalciuria. N Engl J Med 306: 1136-1140.
28. Chappard D, Minaire P, Privat C, Berard E, Mendoza-Sarmiento J, Tournebise H, Basle MH, Audran W, Rebel A, Picot C. 1995. Effects of tiludronate on bone loss in paraplegic patients. J Bone Min Res 10: 112-118.
29. Bergstrom WH. 1978. Hypercalciuria and hypercalcemia complicating immobilization. Am J Dis Child 132: 553-554.
30. Gaudino A, Pennisi P, Bratengeier C, Torrisi V, Lindner B, Mangiafico RA, Pulvirenti I, Hawa G, Tringali G, Fiore C. 2010. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab 95: 2248-2253.
31. Orwoll ES. 1982. The milk-alkali syndrome: Current concepts. Ann Intern Med 97: 242-248.
32. Beall DP, Scofield RH. 1995. Milk-alkali syndrome associated with calcium carbonate consumption. Medicine 74: 89-96.
33. Holick MF, Shao Q, Liu WW, Chen TC. 1992. The vitamin D content of fortified milk and infant formula. N Engl J Med 326: 1178-1181.
34. Ott SM, Maloney NA, Klein GL, Alfrey AC, Ament ME, Lobourn JW. 1983. Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. Ann Intern Med 96: 910-914.
35. Klein GL, Horst RL, Norman AW, Ament ME, Slatopolsky E, Coburn JW. 1981. Reduced serum levels of l alpha,25-dihydroxyvitamin D during long-term total parenteral nutrition. Ann Intern Med 94: 638-643.
36. Merlini G, Fitzpatrick LA, Siris ES, Bilezikian JP, Birken A, Beychok A, Osserman EF. 1984. A human myeloma immunoglobulin G binding four moles of calcium associated with asymptomatic hypercalcemia. J Clin Immunol 4: 185-196.
37. Elfatih A, Anderson NR, Fahie-Wilson MN, Gama R. 2007. Pseudo-pseudohypercalcaemia, apparent primary hyperparathyroidism and Waldenström's macroglobulinaemia. J Clin Pathol 60: 436-437.
38. Haden ST, Stoll AL, McCormick S, Scott J, Fuleihan GE. 1979. Alterations in parathyroid dynamics in lithiumtreated subjects. J Clin Endocrinol Metab 82: 2844-2848.
39. Porter RH, Cox BG, Heaney D, Hostetter TH, Stinebaugh BJ, Suki WN. 1978. Treatment of hypoparathyroid patients with chlorthalidone. N Engl J Med 298: 577.
40. Wermers RA, Kearns AE, Jenkins GD, Melton LJ 3rd. 2007. Incidence and clinical spectrum of thiazideassociated hypercalcemia. Am J Med 120: 911. e9-911. e15.
41. McPherson ML, Prince SR, Atamer E, Maxwell DB, Ross-Clunis H, Estep H. 1986. Theophylline-induced hypercalcemia. Ann Intern Med 105: 52-54.
42. Saunders MP, Salisbury AJ, O ' Byrne KJ, Long L, Whitehouse RM, Talbot DC, Mawer EB, Harris AL. 1997. A novel cyclic adenosine monophosphate analog induces hypercalcemia via production of 1,25-dihydroxyvitamin D in patients with solid tumors. J Clin Endocrinol Metab 83: 4044-4048.
43. Gayet S, Ville E, Durand JM, Mars ME, Morange S, Kaplanski G, Gallais H, Soubeyrand J. 1997. Foscarnetinduced hypercalcemia in AIDS. AIDS 11: 1068-1070.
44. Knox JB, Demling RH, Wilmore DW, Sarraf P, Santos AA. 1995. Hypercalcemia associated with the use of human growth hormone in an adult surgical intensive care unit. Arch Surg 130: 442-445.
45. Sakoulas G, Tritos NA, Lally M, Wanke C, Hartzband P. 1997. Hypercalcemia in an AIDS patient treated with growth hormone. AIDS 11: 1353-1356.
46. Miller PD, Bilezikian JP, Diaz-Curiel M, Chen P, Marin F, Krege JH, Wong M, Marcus R. 2007. Occurrence of hypercalciuria in patients with osteoporosis treated with teriparatide. J Clin Endocrinol Metab 92: 3535-3541.
47. Valente JD, Elias AN, Weinstein GD. 1983. Hypercalcemia associated with oral isotretinoin in the treatment of severe acne. JAMA 250: 1899.
48. Villablanca J, Khan AA, Avramis VI, Seeger RC, Matthay KC, Ramsay NK, Reynolds CP. 1995. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol 13: 894-901.
49. Valentin-Opran A, Eilon G, Saez S, Mundy GR. 1985. Estrogens stimulate release of bone-resorbing activity in cultured human breast cancer cells. J Clin Invest 72: 726-731.
50. Ellis MJ, Gao F, Dehdashti F, Jeffe DB, Marcom PK, Carey LA, Dickler MN, Silverman P, Fleming GF, Kommareddy A, Jamalabadi-Majidi S, Crowder R, Siegel BA. 2009. Lower-dose vs. high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advance breast cancer. JAMA 302: 774-780.
51. Jacobus CH, Holick MF, Shao Q, Chen TC, Holm IA, Kolodny JM, Fuleihan GE, Seely EW. 1992. Hypervitaminosis D associated with drinking milk. N Engl J Med 326: 1173-1177.
52. Llach F, Felsenfeld AJ, Haussler MR. 1981. The pathophysiology of altered calcium metabolism in rhabdomyolysisinduced acute renal failure. N Engl J Med 305: 117-123.
53. Messa P, Cafforio C, Alfieri C. 2010. Calcium and phosphate changes after renal transplantation. J Nephrol 23 Suppl 16: 175-181.
54. Gerhardt A, Greenberg A, Reilly JJ, Van Thiel DH. 1987. Hypercalcema complication of advanced chronic liver disease. Arch Intern Med 147: 274-277.
55. Chandra SV, Shukla GS, Srivastava RS. 1981. An exploratory study of manganese exposure to welders. Clin Toxicol 18: 407-416.
56. Sarkar S, Hussain N, Herson V. 2003. Fibrin glue for persistent pneumothorax in neonates. J Perinatology 23: 82-84.
57. Schlingman KP, Kaufman M, Weber S, Irwin A, Ulrike J, Misselwitz J, Klaus G, Guran T, Hoenderop JG, Bindels RJ, Prosser DE, Jones G, Konrad M. 2011. Mutations of CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 365: 410-421.